Acrivon Therapeutics, Inc (ACRV): 8-K filed Nov 6, 2026

Form type

8-K

Filing date

Nov 6, 2026

Accession number

0001193125-26-450779

Filer

Acrivon Therapeutics, Inc (CIK 1781174)